FundingsUpdated daily

Biotechnology startup funding in Africa

36 disclosed rounds on the record for this view, newest first.

Updated 6,697 rounds on recordSource: SLA Funding IndexHow we count →Submit a round →

Biotechnology startup funding in Africa36 · newest first

All 6,697 rounds →
#StartupRoundAmountDate
1
ValorigoHealth Care · Kinshasa
SeedNot disclosed31 Jul 2026
2
FluorobiotechBiotechnology · Stellenbosch
Funding RoundNot disclosed13 Mar 2026
3
CroptimusAgTech · Cairo
SeedNot disclosed19 Dec 2025
4
Nawah ScientificBiopharma · Cairo
Debt FinancingNot disclosed15 Dec 2025
5
Giraffe BioenergyEnergy · Nairobi
Funding RoundNot disclosed28 Jul 2025
6
Impulse BiomedicalBiomedical Engineering · Cape Town
VentureNot disclosed16 May 2025
7
Organic FieldsAgTech · Nairobi
Non-equity AssistanceNot disclosed24 May 2024
8
GenePlus Global LimitedAgriculture · Nairobi
Funding RoundNot disclosed23 Mar 2024
9
GenePlus Global LimitedAgriculture · Nairobi
Non-equity AssistanceNot disclosed01 Feb 2024
10
FluorobiotechBiotechnology · Stellenbosch
SeedNot disclosed01 Jan 2024

SLA Funding Index · as of 18 Oct 2026

Your view shows the first 10 rounds of each search.

Questions about Biotechnology startup funding in Africa

How many funding rounds did Biotechnology startups in Africa raise?
36 disclosed rounds are on the StartupList Africa record for this view as of 18 Oct 2026, listed newest first.
How often is funding data updated?
Our funding database is updated daily. We track disclosed rounds from press releases, regulatory filings, investor announcements, and verified startup submissions.
What funding stages are tracked?
We track all stages including Pre-Seed, Seed, Series A through Series E+, as well as alternative capital types like angel investments, grants, debt financing, and convertible notes.
How is the funding amount determined?
Amounts shown are the disclosed USD equivalent at the time of announcement. Where the round was denominated in local currency, we convert using the exchange rate on the announcement date.